Product Information
AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) is a brand product labeled by Biogen Inc., priced at $8772.0250 per EA under NDC 59627033304. Its NADAC has been published 597 times since Apr 29, 2015.
Manufacturer
Biogen Inc.NDC
59627033304
Classification
Brand
Dosage Form
KIT
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Approval Type
Biologic (BLA)
FDA Application
BLA103628On Market Since
8/29/2014
Price Statistics
The NADAC for AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) has been published 597 times since Apr 29, 2015, and over the history we have for it it has risen 79.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8772.0250 per EA |
|---|---|
| All-time high | $8837.2486 (Sep 16, 2026) |
| All-time low | $4896.5720 (May 20, 2015) |
| 52-week high | $8837.2486 |
| 52-week low | $8406.9391 |
| Median price | $6995.3895 |
| Average price | $6994.0894 |
| Largest weekly change | +8.0% (Jan 11, 2017) |
| Weeks tracked | 597 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
interferon beta-1a market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK)?
The current National Average Drug Acquisition Cost (NADAC) for AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK), manufactured by Biogen Inc., is $8772.0250 per EA (NDC 59627033304), effective Sep 30, 2026.
How has the price of AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) changed over time?
Over the history we have for it, the NADAC for AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) has risen 79.0%. It has been tracked across 597 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK)?
Since Apr 29, 2015, the NADAC for AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) has ranged from a low of $4896.5720 (May 20, 2015) to a high of $8837.2486 (Sep 16, 2026), with a median of $6995.3895 per EA.
Are there cheaper alternatives to AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) in a comparable dosage form, but none are currently priced below it.
Who manufactures AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK)?
AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK) (NDC 59627033304) is labeled by Biogen Inc., and CMS classifies it as a brand product.